Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05199233 · ClinicalTrials.gov registry record · NA
Mindfulness Intervention for Post-Covid Symptoms
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT05199233: Completed NA study, sponsored by Mayo Clinic.
NCT05199233 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05199233, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the feasibility of using a wearable brain-sensing wellness device (Muse-S) to potentially reduce stress and anxiety during Post-Covid, which is characterized by increased stress and anxiety.
Interventions
- DEVICE Muse S™ Headband system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2022-06-01 |
| Est. Completion | 2024-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05199233
The ClinicalTrials.gov registry entry for NCT05199233 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Muse S™ Headband system is the first listed.
NCT05199233 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05199233 about?
NCT05199233 is a clinical study titled "Mindfulness Intervention for Post-Covid Symptoms". The purpose of this study is to assess the feasibility of using a wearable brain-sensing wellness device (Muse-S) to potentially reduce stress and anxiety during Post-Covid, which is characterized by increased stress and anxiety.
What is the current status of trial NCT05199233?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2022-06-01. Estimated completion is 2024-12-31.
What interventions are being tested in trial NCT05199233?
The interventions under investigation include: Muse S™ Headband system (DEVICE).
Who is sponsoring clinical trial NCT05199233?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.